Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Glendale, CO
SEC filing record 1 source field available
Fiscal year end
30 June
NEXIEN BIOPHARMA, INC. has filed 201 SEC EDGAR filings since 14 Nov 2014

SEC filing history

Showing 76-100 of 201 matching filings.

Per page
25
Current page
4
8-K File 000-55320

8-K filing

Filing date
29 Mar 2019
Reporting date
29 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55320

8-K filing

Filing date
08 Mar 2019
Reporting date
08 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-55320

DEF 14C filing

Filing date
08 Mar 2019
Reporting date
08 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55320

8-K filing

Filing date
05 Mar 2019
Reporting date
05 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55320

8-K filing

Filing date
26 Feb 2019
Reporting date
26 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55320

10-Q filing

Filing date
14 Feb 2019
Reporting date
31 Dec 2018
Next action
Verify source filing
8-K File 000-55320

8-K filing

Filing date
06 Dec 2018
Reporting date
05 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-55320

10-Q filing

Filing date
14 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
08 Nov 2018
Reporting date
26 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55320

8-K filing

Filing date
05 Nov 2018
Reporting date
05 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
02 Nov 2018
Reporting date
26 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
01 Nov 2018
Reporting date
26 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
31 Oct 2018
Reporting date
26 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Oct 2018
Reporting date
26 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55320

8-K filing

Filing date
30 Oct 2018
Reporting date
26 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Oct 2018
Reporting date
01 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Oct 2018
Reporting date
26 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55320

8-K filing

Filing date
19 Oct 2018
Reporting date
19 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55320

8-K filing

Filing date
01 Oct 2018
Reporting date
25 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-55320

10-K filing

Filing date
28 Sep 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
8-K File 000-55320

8-K filing

Filing date
12 Sep 2018
Reporting date
12 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Sep 2018
Reporting date
06 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Sep 2018
Reporting date
08 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Sep 2018
Reporting date
08 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-55320

8-K filing

Filing date
22 Aug 2018
Reporting date
22 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .